Cas 1193104-15-2,(R)-2,2-dimethyl-4-[(3-nitrophenoxy)methyl]-1,3-dioxolane

1193104-15-2

Post Buying Request

Basic information

Product Name: (R)-2,2-dimethyl-4-[(3-nitrophenoxy)methyl]-1,3-dioxolane
Synonyms: (R)-2,2-dimethyl-4-[(3-nitrophenoxy)methyl]-1,3-dioxolane
CAS NO:1193104-15-2
Molecular Formula:
Molecular Weight: 253.255
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (R)-2,2-dimethyl-4-[(3-nitrophenoxy)methyl]-1,3-dioxolane(CAS DataBase Reference)
NIST Chemistry Reference: (R)-2,2-dimethyl-4-[(3-nitrophenoxy)methyl]-1,3-dioxolane(1193104-15-2)
EPA Substance Registry System: (R)-2,2-dimethyl-4-[(3-nitrophenoxy)methyl]-1,3-dioxolane(1193104-15-2)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1193104-15-2(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1193104-15-2 Suppliers

Recommended suppliers

1193104-15-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1193104-15-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,3,1,0 and 4 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1193104-15:
(9*1)+(8*1)+(7*9)+(6*3)+(5*1)+(4*0)+(3*4)+(2*1)+(1*5)=122
122 % 10 = 2
So 1193104-15-2 is a valid CAS Registry Number.

1193104-15-2Upstream product

1193104-15-2Downstream Products

1193104-16-3 (R)-3-((2,2-dimethyl-1,3-dioxolan-4-yl)methoxy)aniline

1193104-15-2Relevant academic research and scientific papers

SUBSTITUTED BICYCLIC AZA-HETEROCYCLES AND ANALOGUES AS SIRTUIN MODULATORS

-

Paragraph 0823; 0824, (2017/04/04)

Provided herein are novel substituted bicyclic aza-heterocycle sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. Also provided are compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.

QUINOLINES AND RELATED ANALOGS AS SIRTUIN MODULATORS

-

Paragraph 0274-0276, (2016/08/17)

Provided herein are novel sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. Also provided are compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.

SUBSTITUTED BICYCLIC AZA-HETEROCYCLES AND ANALOGUES AS SIRTUIN MODULATORS

-

Page/Page column 203; 204, (2013/05/09)

Provided herein are novel substituted bicyclic aza-heterocycle sirtuin- modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. Also provided are compositions comprising a sirtuin- modulating compound in combination with another therapeutic agent.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1193104-15-2